Really interesting finding and thread that Muge Cevik sums up with this tweet:

Grain of salt: It may explain why disease might be less severe from Omicron, though as every responsible scientist I’ve seen discussing this finding will point out: severity is also going to be heavily dependent on individual immune response.

Somewhat offtopic, I found TWiV 841 fascinating to hear. I always appreciate the way they communicate to non-experts, but they had a mostly easy to follow discussion about a paper studying a variety of vaccines and measurements of their protection on a different respiratory virus, which lead to very clear arguments about why layman, and not so layman, discussions miss a lot of marks about what it all means. And one of the conclusions is that we have been very lucky with things we barely understand, but, hey, mRNA vaccines rock, and we got them now.
Highly recommend listening to it.

Here is a question i have, we normally use postive test rate to gived us a gauge about how much of a population is infected but untested correct? So my question is there any data on Omicron being less or more likely to be undiagnosed?

The underlining question is, are people having a more severe initial response with Omicron and thus getting tested to a greater percentage than Delta?

The 80% increase of people under 50 going to the hospitalized in that one SA study makes me wonder if the mild symptoms common with the previous versions means that mild symptoms could be less common with Omicron (considering the 80% increase of symptomology in younger patients), thus helping spike numbers. Is there any specific analysis on that?

This is interesting, and may be part of the Omicron puzzle.

“Further work is needed” being a good takeaway as well here.

It would make sense that once all (or many) potential hosts have been either infected or vaccinated, a new optimum can be found by trading off some efficiency in infection for being able to avoid the immune response.

On the one hand I’m am constantly amazed by the pace of scientific progress during this pandemic. On the other, I am (totally irrationally) constantly maddened at the pace of scientific progress during this pandemic.

There’s just so much we don’t know about omicron, though at least we’re starting to get a sense of what unknowns we need to know.

For the remaining naive population, the difference between immunity and intrinsic reduced severity is going to matter quite a bit. I wonder how resistance to severe disease scales with 0,1,2,3 prior exposures (via either natural infection or vaccination.) We mostly have the 2,3 numbers from vaccination or vaccination + infection or vaccination + boost. I wonder if the people in the 1 category “I got covid already, I don’t need to get vaccinated!” will do.

Yeah, I think he meant “at the population level” but even there it definitely seems like it would matter, and for individual outcomes it’s obviously a huge issue. Not sure why that bit is what got excerpted though, this is the part I thought was most interesting, regarding what’s going on with the SA data:

I’m curious to talk to you about the state of play generally, but I wanted to start with what we’re seeing in Gauteng, where the wave already appears to be cresting, though many fewer people appear to have been infected than are vulnerable — especially when you consider that, while people who’ve been infected or vaccinated already may be protected against severe disease, there is hardly any protection against infection per se. Which means, in terms of infection, this is almost a virgin population, so to speak. How do you understand that?
Yeah, it’s a really good question. I’ve been looking into this a bit. The basic idea is that we can measure Rt, and there’s a very simple equation that will convert Rt into your population attack rate: how many people will be infected in the entire epidemic wave. That projection is quite linear. With Delta and the Delta Rt of 1.5 — when it was coming in — I was able to convert that to an attack rate that ultimately matched what we saw. I did that by assuming it would really be mostly targeting the people that aren’t vaccinated or infected previously.

With Omicron, and its initial Rt being three-ish, that same equation should give you something like 90 percent of the population infected. But from what we’ve seen in South Africa, it seems like the wave is crashing well before that. So something is going on.

What do you think it is?
The options that I have been thinking about — there’s five of them. They’re non mutually exclusive. So to go through …

Please.
First, there’s the simple limit to testing capacity. As things increase, our testing capacity doesn’t increase as fast, and so we’re missing more and more cases. That can give you a distorted picture — it could look like a plateau in Gauteng, but you could imagine it’s really a much higher crest.

Like the top of a mountain has been chopped off by bad testing.
I also bet we can expect a lot more underreporting of Omicron, compared to previous wave, because it’s more mild, either through existing immunity or through actual reduction of intrinsic severity. And if, on average, you’ve reduced the severity of cases, there’d be a lot of people that don’t bother to come to the hospital or to get tested. And so as a rough guess, you might go from like one in ten cases reported in South Africa to one in 20 or even one in 30 cases — that wouldn’t seem unreasonable to me. And that makes it so that at the same caseload of Delta versus Omicron you could actually have three times as many infections with Omicron.

We could also have a change in generation interval. If we have Omicron kind of doubling at this very fast two- or three-day rate, you don’t actually have to have Rt be three. You could have actually just made the whole thing faster without having the number of secondary infections being much higher. And we don’t have no way of knowing that at this moment.

The last two are, it might not be that the entire population is susceptible to Omicron. Maybe half the population is susceptible. And then, finally, I think there’s a network effect — that as things kind of percolate through the community, you can imagine those transmission chains circling back on themselves and hitting someone that has already been exposed.

An interesting study, with all kinds of caveats:

  1. Preprint, not peer-reviewed
  2. Based upon simulation
  3. Does feel a bit like cutting your own puzzle pieces to fit a picture.

Those grains of salt fully taken…

Our simulations suggest that while there is significant reduction of antibody binding strength corresponding to escape, the omicron spike pays a cost in terms of weaker receptor binding. The furin cleavage domain is the same or weaker binding than the alpha variant, suggesting less viral load and disease intensity than the extant delta variant.

An updated version of the Imperial College study from last week on Omicron severity in the UK, with more data.

Table 3 is the bit that’s probably most interesting to people.

The good news is that they’re seeing a 25% reduction in hospitalization risk for Omicron cases when compared to Delta cases even for unvaccinated people with no prior record of a Covid infection. That would suggest a reduction in the intrinsic severity.

The situation with pre-existing cases is more nuanced, and the data seems very likely to misinterpreted. If we look at the various PF/MD:D2:14+ and PF/MD:D3:14+ rows in the table, we see the following:

  • A 75% reduction in hospitalization risk for Omicron cases who were double-vaccinated with a mRNA vaccine, compared to unvaccinated Delta cases.
  • A 65% reduction in hospitalization risk for Omicron cases with a booster vaccine, compared to unvaccinated Delta cases.

Note that all of these numbers are conditional on detected cases, unlike most of the vaccine efficacy studies we’ve seen in the past. The real risk reduction would be multiplicative with the reduction in the risk of being infected. E.g. it’s not the case that having the booster increases the risk compared to just having a double-vaccination.

But then if we compare the above to the outcomes for vaccined people who got Delta, the table has:

  • A 75% reduction in risk for double-vaccinated Delta cases vs. unvaccinated Delta cases
  • A 70% reduction in risk for boosted Delta cases vs. unvaccinated Delta cases

These are basically the same risk reductions as we had for Omicron… Isn’t the implication then that the breakthrough cases will be more numerous but not any milder?

Hey! It’s public health data/study on Gauteng Province in the RSA on Omicron.

But special catch for any neocolonialists out there: it’s a preprint for The Lancet, so now maybe we can pay attention to data from this country, which does a lot more to study virology and infectious disease than all but a few countries on the planet.

Whole thing is worth a read, but here are the takeaways:

Latest UK data, for people that love data.

https://www.nature.com/articles/s41591-022-01715-4

Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern

Infection-neutralizing antibody responses after SARS-CoV-2 infection or COVID-19 vaccination are an essential component of antiviral immunity. Antibody-mediated protection is challenged by the emergence of SARS-CoV-2 variants of concern (VoCs) with immune escape properties, such as omicron (B.1.1.529) that is rapidly spreading worldwide. Here, we report neutralizing antibody dynamics in a longitudinal cohort of COVID-19 convalescent and infection-naive individuals vaccinated with mRNA BNT162b2 by quantifying anti-SARS-CoV-2-spike antibodies and determining their avidity and neutralization capacity in serum. Using live-virus neutralization assays, we show that a superior infection-neutralizing capacity against all VoCs, including omicron, developed after either two vaccinations in convalescents or after a third vaccination or breakthrough infection of twice-vaccinated, naive individuals. These three consecutive spike antigen exposures resulted in an increasing neutralization capacity per anti-spike antibody unit and were paralleled by stepwise increases in antibody avidity. We conclude that an infection-plus-vaccination-induced hybrid immunity or a triple immunization can induce high-quality antibodies with superior neutralization capacity against VoCs, including omicron.